Showing 1,541 - 1,560 results of 110,660 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((g decrease) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 1541
  2. 1542
  3. 1543
  4. 1544
  5. 1545
  6. 1546
  7. 1547
  8. 1548
  9. 1549

    GSK343 decreased neuroblastoma viability, proliferation, and motility. by Laura V. Bownes (10276762)

    Published 2021
    “…<p>(A) SK-N-AS, SK-N-BE(2), SH-EP and WAC(2) cells (1.5 × 10<sup>3</sup> cells) were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and viability was measured using alamarBlue<sup>®</sup> assay. …”
  10. 1550
  11. 1551
  12. 1552

    Postnatal CDPPB treatment decreased [<sup>11</sup>C]PBR accumulation in saline-exposed offspring, but not in offspring prenatally exposed to LPS. by Dany Arsenault (229311)

    Published 2015
    “…<p>Postnatal CDPPB treatment decreased the accumulation of [<sup>11</sup>C]PBR in the olfactory bulb, cerebellum, hippocampus, striatum, hypothalamus and the whole brain of the offspring prenatally exposed to saline solution (A). …”
  13. 1553

    Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

    Published 2015
    “…Two of the five siRNAs tested were found to efficiently inhibit mRNA of both <i>TMPRSS2-ERG</i> variants and to decrease ERG protein expression. …”
  14. 1554

    PARP inhibition causes a decrease in Alt-EJ that is enhanced by Ku70 loss. by Sean M. Howard (687174)

    Published 2015
    “…Shown are the immunoblot signals for PARylated protein and actin after treatment of U2OS cells with 5 μM of the PARPi Olaparib (2 days). Also shown is the cell cycle profile of siCTRL treated U2OS cells incubated with 5μM Olaparib (Olap), or mock treated (UN) prior to BrdU labeling and PI staining as in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004943#pgen.1004943.g002" target="_blank">Fig. 2C</a>. …”
  15. 1555
  16. 1556
  17. 1557
  18. 1558

    Depletion of SNEV decreases the splicing efficiency of nuclear extracts by Johannes Grillari (13055)

    Published 2011
    “…While neither IgG nor an irrelevant antibody directed against HCF reduce the amount of SNEV in the nuclear extracts used in the splicing assay after immunodepletion, a marked decrease in SNEV was observed after depletion with α-SNEV antibody. …”
  19. 1559
  20. 1560